TRIM26 and nonpapillary renal cell carcinoma: Gain- and loss-of-function tests demonstrated that the overexpression of TRIM26 suppressed cell proliferation, migration, invasion, and the epithelial-mesenchymal transition (EMT) process in clear cell renal cell carcinoma (ccRCC).